Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenuehttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue
AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses: https://mms.businesswire.com/media/20240318771746/en/2069563/5/EVO_-_3M_Lens_commas.jpg
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

Is Rithm Capital Stock a Buy?: https://g.foolcdn.com/editorial/images/768660/stock-trading-person-getty-2022.jpg
Is Rithm Capital Stock a Buy?

Dividend stocks can be an excellent source of passive income, and Rithm Capital (NYSE: RITM) is one of the highest-yielding dividend stocks you can buy today. Its 9.1% dividend yield makes it an

AEVIS VICTORIA SA  - Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA - Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024
AEVIS VICTORIA SA - Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
Why Nevro Stock Lagged the Market on Thursday: https://g.foolcdn.com/editorial/images/766494/medical-professional-holding-dollar-sign-paperweight.jpg
Why Nevro Stock Lagged the Market on Thursday

Specialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the company's release of its fourth-quarter

Why Trupanion Stock Plummeted Today: https://g.foolcdn.com/editorial/images/765763/cat-being-seen-by-vet-with-stethoscope.jpg
Why Trupanion Stock Plummeted Today

Shares of Trupanion (NASDAQ: TRUP) plunged 35% on Friday after an accounting controls warning overshadowed better-than-expected preliminary fourth-quarter results from the pet insurance provider.

Social Security Has a Big Immigration Problem -- but It's Probably Not What You Think: https://g.foolcdn.com/editorial/images/763274/getty-curious-person-wondering-interested.jpg
Social Security Has a Big Immigration Problem -- but It's Probably Not What You Think

A recent survey conducted by the Nationwide Retirement Institute revealed that retirees view inflation and potential Social Security benefit cuts as their biggest concerns. And the Harvard

STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision: https://mms.businesswire.com/media/20240123947715/en/2006414/5/SV_PR4.jpg
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, and

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
Why AngioDynamics Stock Got Destroyed Today: https://g.foolcdn.com/editorial/images/760351/1-big-red-arrow-going-down-over-a-stock-chart.jpg
Why AngioDynamics Stock Got Destroyed Today

Investors in AngioDynamics (NASDAQ: ANGO), inventor of the innovative Nanoknife device for electrocuting cancer cells, got an unpleasant shock of their own on Friday morning. Though the company

Why Pure Storage Stock Was a Big Winner on Wednesday: https://g.foolcdn.com/editorial/images/760099/finger-about-to-press-a-green-dollar-sign-key-on-a-pc-keyboard.jpg
Why Pure Storage Stock Was a Big Winner on Wednesday

Niche tech stock Pure Storage (NYSE: PSTG) had a fine Wednesday on the market, with its shares racing nearly 5% higher in value. By contrast, the S&P 500 index slumped by 0.8%. Investors were

EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
Why Trupanion Stock Soared Today: https://g.foolcdn.com/editorial/images/753724/veterinarian-with-cat.jpg
Why Trupanion Stock Soared Today

Shares of Trupanion (NASDAQ: TRUP) rallied as much as 30% early Friday, then settled to trade up 16.7% as of 2:45 p.m. ET after the pet insurance provider announced better-than-expected

AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2023 http://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2023
AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023
EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
3 Dental Supply Stocks You Can Sink Your Teeth Into: https://g.foolcdn.com/editorial/images/751961/sitting-at-dental-chair-dentist-patient.jpg
3 Dental Supply Stocks You Can Sink Your Teeth Into

Like regular flossing, dental supply companies are sometimes overlooked, but Henry Schein (NASDAQ: HSIC), Dentsply Sirona (NASDAQ: XRAY), and Patterson Companies (NASDAQ: PDCO) are all thriving

Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?: https://g.foolcdn.com/editorial/images/750992/dna-on-monitor-scientists.jpg
Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?

Cathie Wood isn't known for being a value investor. However, the Ark Invest CEO won't pass up the opportunity to scoop up shares of innovative companies when they're available at a lower price.

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised: https://assets2.sharewise.com/attachment/file/24054/375px-Dr%C3%A4ger_Logo.svg.png
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised
Goldin Wins Nobel Prize for Studies of Women in Workplace: https://g.foolcdn.com/editorial/images/750746/featured-daily-upside-image.png
Goldin Wins Nobel Prize for Studies of Women in Workplace

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Now here is a